Mitomycin C, Thermo Scientific Chemicals
Mitomycin C, Thermo Scientific Chemicals
Mitomycin C, Thermo Scientific Chemicals
Mitomycin C, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Mitomycin C, Thermo Scientific Chemicals

Mitomycin C, CAS # 50-07-7, is a methylazirinopyrroloindoledione compound showing antineoplastic and antibiotic activities. It is active against a broad-spectrum of gram-positive, gram-negative, and acid-fast bacilli bacteria.
Have Questions?
Catalog NumberQuantity
FSKJ63193.MA10 mg
Catalog number FSKJ63193.MA
View Price:Sign in to see your account pricing. Need an account? Register with us today.
Quantity:
10 mg
Request bulk or custom format
Specifications
Chemical Name or MaterialMitomycin C
TypeMitomycin C
Physical FormPowder
CAS50-07-7
Health Hazard 1H301-H351-H373
View more
Mitomycin C is used as a chemotherapeutic agent due to its antitumor activity. It is used to treat upper gastro-intestinal cancers. It serves as an antineoplastic agent which inhibits DNA synthesis and induces apoptosis.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Mitomycin C is a methylazirinopyrroloindoledione compound isolated from the bacterium Streptomyces caespitosus, and other Streptomyces bacterial species that has antineoplastic and antibiotic activities
• This compound acts as an inhibitor of DNA synthesis, nuclear division, as well as an apoptosis inducer. It can create oxygen radicals, and produce inter-strand DNA crosslinks, inhibiting DNA synthesis
• Mitomycin C shows alkylating activity and mainly targets the guanine nucleoside sequence 5′-CpG-3′. It inhibits DNA synthesis by covalently reacting with DNA, forming crosslinks between complementary strands of DNA. Consequently, this interaction prevents the separation of complementary DNA strands, inhibiting DNA replication

Application

• Mitomycin C is active against a broad-spectrum of gram-positive, gram-negative, and acid-fast bacilli bacteria
• Mitomycin C has strong antineoplastic activity, mainly against Ehrlich ascites tumor cell lines
• This compound can inhibit B and T cells and macrophage proliferation. It can also impair antigen presentation, as well as the secretion of interferon-γ, TNF- α, and IL-2
• This compound is used to generate mitotically inactive feeder cells in cell culture systems, such as the mitotically inactive fibroblasts used in embryonic stem cell systems
• It has been used to treat basal-like cancer cell line in vitro experiments
• It is particularly toxic to hypoxic cells inhibiting RNA and protein synthesis at high concentrations

RUO – Research Use Only

General References:

  1. Yan, C.; Kong, D.; Ge, D.; Zhang, Y.; Zhang, X.; Su, C.; Cao, X. Mitomycin C Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via a Mitochondrial-Mediated Pathway. Cell. Physiol. Biochem. 2015, 35 (3), 1125-1136.
  2. Camarasa, M.; Brison, D.; Kimber, S.; Handyside, A. Naturally immortalised mouse embryonic fibroblast lines support human embryonic stem cell growth. Cloning Stem Cells. 2009, 11, (3), 453-62.
  3. Mao, Y.; Varoglu, M.; Sherman, D. Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564. Chem Biol. 1999, 6, (4), 251-263.
  4. Tai, T. Y. T.; Moster, M. R.; Pro, M. J.; Myers, J. S.; Katz, L. J. Needle Bleb Revision with Bevacizumab and Mitomycin C Compared With Mitomycin C Alone for Failing Filtration Blebs. J. Glaucoma 2015, 24 (4), 311-315.